Details of Drug-Drug Interaction
| Drug General Information (ID: DDIC1A253O) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Oxytocin | Drug Info | Succinylcholine | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Uterotonic Agents | Analgesics | |||||||
| Structure | |||||||||
| Mechanism of Oxytocin-Succinylcholine Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Additive neuromuscular blocking effects Click to Show/Hide Mechanism Graph | |||||||||
![]() |
|||||||||
| Drug Name | Oxytocin | Succinylcholine | |||||||
| Mechanism | Neuromuscular blocking effects |
Neuromuscular blocking agent Neuronal acetylcholine receptor Antagonist |
|||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Neuronal acetylcholine receptor | Structure Sequence | |||||||
| Protein Family | Ligand-gated ion channel (TC 1.A.9) family | ||||||||
| Protein Function |
After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
Click to Show/Hide
|
||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Observation for profound and prolonged respiratory depression and muscle weakness is recommended if these drugs must be used together. | ||||||||
| References | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Multum Information Services, Inc. Expert Review Panel. | ||||||||||||||||||
| 2 | Product Information. Anectine (succinylcholine). Glaxo Wellcome, Research Triangle Park, NC. | ||||||||||||||||||

